India’s medical technology industry is entering a transformative phase. Once recognised mainly as a cost-efficient manufacturing base for consumables and disposables, the sector is steadily evolving into an innovation driven ecosystem with growing global relevance. Supported by stronger industry capabilities and favourable policy measures, India is positioning itself as a credible global MedTech hub
A major shift has been the changing perception of made in India medical devices. For many years, domestic products were viewed primarily through the lens of affordability rather than quality or innovation. That narrative is now changing. Indian manufacturers have significantly improved quality standards, aligned with international regulatory expectations, and enhanced product reliability. This progress is being driven by higher investments in research, engineering, and clinical validation. Indian MedTech companies are increasingly investing in intellectual property creation and advanced product development.
Government initiatives have also played a critical role in strengthening the sector. The Production-Linked Incentive (PLI) scheme for medical devices, initiatives supporting import substitution and clinical research, and the development of medical device parks have all contributed toward improving domestic manufacturing capabilities and reducing import dependence. To maintain this momentum, the government should consider extending the PLI scheme by another four to five years and expanding it to cover a wider range of product categories. A broader and longer-term framework would encourage greater investments in advanced technologies and support the growth of a stronger domestic manufacturing ecosystem.
At the same time, India’s MedTech regulatory landscape has evolved considerably. The Central Drugs Standard Control Organisation (CDSCO) has brought greater structure and maturity to the sector through a more comprehensive regulatory framework. As a result, standards related to safety, quality, and performance have improved significantly. This has enabled Indian companies to gradually move from low-technology products toward more advanced and mid-technology segments. While consumables and disposables continue to dominate exports, Indian manufacturers are increasingly establishing their presence in areas such as cardiac devices, orthopaedic implants, and other specialised technologies.
Ultimately, the biggest beneficiary of this transformation is the patient. Increased domestic manufacturing, combined with better quality and innovation, can make advanced healthcare technologies more accessible and affordable. This aligns with India’s broader healthcare goals while also strengthening the country’s position as a reliable global supplier of medical devices.
However, sustaining and accelerating this growth will require stronger collaboration between the MedTech industry and healthcare providers. Healthcare innovation cannot happen in isolation. Medical devices and technologies must be developed with a deeper understanding of realworld clinical challenges. Too often, products are designed without sufficient engagement with end users. Going forward, hospitals, clinicians, and MedTech companies need to work together to co-create solutions that are practical, effective, and clinically relevant.
Academic institutions can play a vital role in enabling this collaboration. Organisations such as IITs and NIPERs can act as bridges between industry and clinical practice by bringing together engineers, researchers, and healthcare professionals. Such interdisciplinary collaboration can accelerate the development of globally competitive technologies that are also aligned with local healthcare needs.
There is also a growing need for closer cooperation in the training and development of healthcare professionals. Continuous education, handson learning, and regular upskilling are essential for ensuring the safe and effective use of modern medical technologies. Stronger partnerships between hospitals and MedTech companies can help bridge knowledge gaps, improve clinical outcomes, and ensure that innovation translates into better patient care.
India’s strengths in engineering, information technology, and digital innovation provide another major advantage for the sector. The convergence of MedTech with artificial intelligence, data analytics, digital health platforms, and remote care solutions is opening new possibilities in diagnostics, precision medicine, and connected healthcare delivery. Leveraging this technological capability effectively will be key to building next-generation healthcare solutions.
Another important factor influencing the adoption of advanced technologies is health insurance coverage. As medical technologies evolve, reimbursement support becomes increasingly important for patient access. Insurance providers need to expand coverage for innovative medical devices and treatments to ensure affordability and wider adoption. In this context, stronger engagement between healthcare providers, the MedTech industry, and insurers will be essential.
India’s MedTech industry today stands at the beginning of a new era defined by innovation, capability, and collaboration. The foundations for long-term growth are already in place – supportive government policies, improving regulatory systems, strong engineering talent, increasing global integration, and a rapidly growing domestic industry.
The next phase of growth will depend on how effectively these strengths are brought together. By aligning innovation with clinical needs, continuing to invest in quality and R&D, and building stronger partnerships among industry, academia, healthcare institutions, insurers, and policymakers, India can move beyond being seen only as a cost-efficient manufacturing destination and emerge as a global leader in medical technology. In doing so, the country will not only strengthen its own healthcare system but also contribute significantly toward improving patient outcomes across the world.